Introduction
============

Metalworking Fluids and Their Aerosols
--------------------------------------

Metalworking fluids (MWF) are used to lubricate and cool tools and the workpiece, as well as flush away metal chips during machining, cutting, grinding, and drilling of metals in many manufacturing processes, from small parts in the watch-making industry to large parts in the automotive or steel industries. MWF are classified into two main families \[[@ref1]\]: (1) Straight MWF that is mineral oil containing no water; and (2) Aqueous MWF that regroup so-called soluble oils and semisynthetic fluids according to the amount of mineral oils emulsified in water, as well as synthetic fluids that contain no mineral oil. Depending on their type and use, MWF may contain lubricity, antimisting or antiwear additives, corrosion inhibitors and biocides, as well as perfumes or coloring agents.

Other substances potentially present in the aerosols from used MWF are the result of thermal degradation or contamination of the machined metal parts. Thus, MWF may contain: (1) polycyclic aromatic hydrocarbons (PAHs) due to lack of an initial refining stage or due to thermal degradation; (2) nitrosamines, present in aqueous MWF as by-products of the reaction between secondary amines and nitrite; or (3) microorganisms like bacteria or mycobacteria that may be growing in tanks containing aqueous MWF.

The physical process of metalworking generates a complex MWF aerosol consisting of droplets (the oil mist), which may contain solid particles (eg, metals), and a vapor phase (air or organic vapors). This vapor phase is the result of the evaporation of volatile or semivolatile constituents from the MWF in contact with the hot cutting zone. These aerosols can reach the workers' breathing zone and may remain in suspension for several hours \[[@ref1]\]. The size distribution of the MWF aerosols is highly variable (median aerodynamic diameters ranging from 1.8-17 µm) and may contain ultrafine particles (aerodynamic diameter \<0.1µm) \[[@ref2]\]. MWF aerosols may be inhaled or enter the body through skin contact. Exposure from soiled clothing and ingestion (hand to mouth contamination) are also possible. Consequently, assessing occupational exposure to MWF aerosols has many challenges.

Health Effects From Exposure to Metalworking Fluids
---------------------------------------------------

Historically, exposure to poorly refined straight oil-mists has been related to cancer of the skin and the scrotum \[[@ref3]\]. More recently, there is growing evidence of a relationship between exposure to straight MWF and bladder cancer \[[@ref4],[@ref5]\]. As early as the 1990s, exposure to oil-mist was related to acute bronchial hyperresponsiveness, occupational asthma, hypersensitivity pneumonitis, ventilatory impairments and respiratory symptoms \[[@ref6]-[@ref9]\]. Recently, a causal model was applied \[[@ref10]\] to explore the quantitative relationship between exposure to MWF aerosol and chronic obstructive pulmonary disease (COPD).

Presumed Physiopathological Mechanisms
--------------------------------------

Inflammation is hypothesized to be an important process that explains some of the observed health outcomes. Indeed, in vivo chronic exposure to rather high concentrations of different semisynthetic MWF have resulted in inflammation in rat and mice lungs \[[@ref11]\]. In addition, signs of oxidative stress have also been reported on the skin of vitamin E deficient mice exposed to MWF \[[@ref12]\]. Based on this, [Figure 1](#figure1){ref-type="fig"} (adapted from Ayres et al \[[@ref13]\] who presented this mechanism for environmental particulate exposure) summarizes the presumed physiopathological mechanism. Given the multiplicity of health outcomes that have been related to oil-mist exposure, we assumed that the main, common mechanism of these effects was oxidative stress. Briefly, the exposure to the MWF aerosols generates free radicals in the lungs of both exogenous and endogenous origin and thereby causes oxidative stress. This oxidative stress induces inflammation, which ultimately increases the oxidative stress via a feedback mechanism. Thus, this chronic inflammation eventually leads to chronic adverse health effects.

![Presumed physio-pathological mechanism adapted from Ayres et al. (2008).](resprot_v8i8e13744_fig1){#figure1}

Methods
=======

The Study Protocol
------------------

### The Study Objectives

The study protocol very closely followed the mechanistic pathway outlined in [Figure 1](#figure1){ref-type="fig"} by proposing an epidemiological field study in both the Swiss micromechanical industry and the French metal industry. It assessed the exposure to MWF approximating the biological effect dose, the oxidative stress, inflammation, genotoxic cellular modifications, and the early nonspecific effect biomarkers that might be on the pathways that lead to chronic respiratory diseases.

The ultimate objective is to develop exposure reduction strategies based on exposure determinants that best predict MWF-related health outcomes. This ultimate objective is broken down into several partial objectives summarized in [Figure 2](#figure2){ref-type="fig"}. The first primary objective of the study, though, was to establish relationships between the exposure determinants and the exposure measurements. The second primary objective was to establish relationships between occupational exposure, especially oxidative potential, and preclinical and clinical effect markers. There were also two secondary objectives, which included establishing relationships between exposure biomarkers and biomarkers of effect in exhaled breath condensate (EBC) and Urine, as well as establishing relationships between biomarkers of effect, genotoxic effects and respiratory symptoms.

![Schematic presentation of the study objectives.](resprot_v8i8e13744_fig2){#figure2}

### Protocol of the Epidemiological Field Study

A three day long longitudinal study of exposed versus nonexposed workers, after a nonexposed period of at least two days, was conducted in Swiss and French companies. At least 30 workers were exposed to straight oil and 30 workers were exposed to water-based MWF. Nonexposed workers from the participating companies will be included, at a ratio of 2 exposed for 1 nonexposed.

The exclusion criteria for this study were: (1) known chronic or acute respiratory diseases; and (2) known exposure to particulate substances with a potential effect on oxidative stress.

The data collection is summarized in [Figure 3](#figure3){ref-type="fig"}. It will consist of repeated characterization of airborne exposure during two consecutive days and multiple collections of EBC, urine and fractional exhaled nitric oxide (FeNO) in parallel. Buccal cells will be collected once per participant. A questionnaire that explores respiratory symptoms, sociodemographic factors (smoking and clinical history, age, etc), the present job, tasks, personal protective equipment, and the participant's job history will also be applied.

![Schematic presentation of the field study protocol. EBC: exhaled breath condensate; FeNO: fractional exhaled nitric oxide.](resprot_v8i8e13744_fig3){#figure3}

EBC will be collected at the beginning of the shift on Day 1 and at the end of Day 2. Urine samples will be collected at the beginning of shift on Days 1, 2 and 3 as well as at the end of the shift on Days 1 and 2. The FeNO will be measured at the beginning and end of shift on Days 1 and 2. The exposure measurements will be obtained over the shifts of Day 1 and 2.

In addition to these data, the occupational hygienists will record workers' tasks and the corresponding exposure determinants. Finally, samples of both used and new MWF will be obtained.

Exposure and Health Outcome Assessment
--------------------------------------

[Table 1](#table1){ref-type="table"} summarizes the different outcomes measured during the field study.

###### 

Outcomes measured in the field study.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome type                 Measured outcome                                                                                                                                Method                                                                                                                                                          
  ---------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------
  Exposure determinants        Determinants                                                                                                                                    Questionnaire                                                                                                                                                   

  **Exposure measurements**    \                                                                                                                                               \                                                                                                                                                               

  \                            Personal sampling                                                                                                                               Standard gravimetric exposureOrganic carbonMeasurement of ultrafine particle numbers                                                                            Metropol M-282Thermal degradation methodReal time instrument

  \                            Stationary sampling                                                                                                                             Standard gravimetric exposureOxidative potentialAldehydesMetalsOrganic carbonNO~2~^--\ a^, NO~3~^--\ b^Measurements of ultrafine particle numbers               Metropol M-282Ferrous oxidation-xylenol orange methodMetropol M4 and M66Metropol M122Thermal degradation methodIon chromatographyReal time instrument

  \                            Monitoring of new and used MWF^c^                                                                                                               Oxidative potentialMetalsOrganic carbonBenzo(a)Pyrene                                                                                                           Ferrous oxidation-xylenol orange assayICP-AES^d^Thermal degradation methodHPLC-Fluo^e^

  **Biomarkers of exposure**   \                                                                                                                                               \                                                                                                                                                               

  \                            In exhaled breath condensate                                                                                                                    NO~2~^--^/NO~3~^--^Metals                                                                                                                                       Ion chromatographyICP-MS^f^

  \                            In urine                                                                                                                                        NDELA^g^1-OHP^i^, 3-OHBaP^j^ (PAH^k^ metabolites)Metals                                                                                                         HPLC-MS/MS^h^HPLC-FluoICP-MS

  **Biomarkers of effect**     \                                                                                                                                               \                                                                                                                                                               

  \                            In exhaled breath condensate                                                                                                                    MDA^l^, 8-isoprostane (markers of lipid peroxidation)8-OHdG^m^ (marker of DNA oxidation)Formate, NO~2~^--^/NO~3~^--^ (proposed markers of nitrosative stress)   HPLC-MS/MSHPLC-MS/MSIon chromatography

  \                            In urine                                                                                                                                        MDA, 8-isoprostane (markers of lipid peroxidation)8-OHdG (marker of DNA oxidation)                                                                              HPLC-MS/MSHPLC-MS/MS

  **Other effect markers**     Micronuclei in buccal cells (marker of genotoxicity)Fractional Exhaled Nitric Oxide (marker of eosinophilic inflammation)Respiratory symptoms   Buccal micronucleus cytome assayDirect-reading instrumentStandardized questionnaire                                                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^NO~2~^--^: nitrite

^b^NO~3~^--^: nitrate

^c^MWF: metalworking fluids

^d^ICP-AES: inductively coupled plasma atomic emission spectroscopy

^e^HPLC-Fluo: high-performance liquid chromatography with fluorescence detection

^f^ICP-MS: inductively coupled plasma mass spectrometer

^g^NDELA: N-nitrosodiethanolamine

^h^HPLC-MS/MS: high-performance liquid chromatography coupled to tandem mass spectrometry

^i^1-OHP: 1-hydroxypyrene

^j^3-OHBaP: 3-hydroxybenzo(a)pyrene

^k^PAH: polycyclic aromatic hydrocarbons

^l^MDA: malondialdehyde

^m^8-OHdG: 8-Oxo-2\'-deoxyguanosine

Exposure Determinants
---------------------

Exposure determinants are factors within the workplace that contribute to increasing or reducing exposure concentrations \[[@ref14]\]. A questionnaire has been developed based on the literature \[[@ref1],[@ref15]\] and will be used by the occupational hygienists during the field study.

Multidimensional Features of Exposure
-------------------------------------

### Respirable Aerosol Exposure

The respirable particulate MWF mass fraction from personal and stationary sampling will be determined following a reference gravimetric method (INRS Metropol M-282). As a complement to these measurements, the organic carbon content of the aerosol collected on quartz filters will be determined using a specifically modified thermal degradation method \[[@ref16]\]. The MWF concentration of the volatile organic fraction will be sampled using a sorbent tube and analyzed chemically. The combination of these measurements will be used to evaluate the overall airborne MWF.

### Oxidative Potential

Using the particulate oxidative potential as an additional metric for evaluating possible toxic effects is a relatively new concept and has rarely been used in occupational health studies. In our study, the oxidative potential of the MWF themselves (new and used) for the respirable fraction of the aerosol, as well as for the gaseous phase, will be quantified. The oxidative potential method used will be based on the ferrous oxidation-xylenol orange method \[[@ref17]\]. Briefly, MWF was sampled with a teflon filter for the particulate phase followed by a XAD-2 sorbent tube for the gaseous phase. An acidic solution of iron(II) (Fe^2+^) with xylenol orange as the indicator and sorbitol as a catalyst (ferrous ion oxidation \[FOX\] solution) was prepared. Oxidation of Fe^2+^ to iron(III) (Fe^3+^) was followed by calorimetry using a spectrometer. Increasing hydrogen peroxide (H~2~ O~2~) (aq) (0-10 uM) concentrations were used for calibration for the filters and in dimethyl sulfoxide for the XAD-2 sorbent. The teflon filter with the particulate MWF was punched and dropped into the FOX solution, vortexed (1 min), and analyzed. The XAD-2 sorbent was desorbed with dichloromethane, evaporated, resuspended in dimethyl sulfoxide, and analyzed.

### Components in the Metalworking Fluid Aerosol

The metal content (eg, iron (Fe), copper (Cu), aluminum (Al), zinc (Zn), manganese (Mn), antimony (Sb), cobalt (Co), nickel (Ni), chromium (Cr), molybdenum (Mo), vanadium (V) and titanium (Ti)) of the aerosol will be measured using stationary samples with cellulose acetate filters, which will be mineralized and analyzed using inductively coupled plasma atomic emission spectroscopy (ICP-AES). Finally, aldehyde concentrations including acetaldehyde and formaldehyde will be quantified.

### Real Time Measurement of Ultrafine Particles

Exposure to ultrafine particles might be related to adverse health effects, and ultrafine particles are present in MWF aerosol \[[@ref2]\]. Particle number concentration of ultrafine particles will be measured using a real time particle counter (DiscMini) in the 10-500 nm range. The particle size distribution between 0.25-32 µm will be determined with an optical particle counter (Grimm Optical Particle Counter 1.109, 31 channels).

Exposure Biomarkers
-------------------

EBC is an emerging technique that is simple, noninvasive and allows scientists to study processes in the lungs \[[@ref18]\]. The metal concentrations in EBC (eg, Fe, Mn, Cr, Ni, Cu, Zn) will be determined with an inductively coupled plasma mass spectrometer (ICP-MS) using the analytical Totalquant technique with external calibration \[[@ref19],[@ref20]\].

We will measure the following urinary exposure biomarkers: metals (27 metals), a nitrosamine (N-nitrosodiethanolamine \[NDELA\]) and two PAH metabolites (1-hydroxypyrene \[1-OHP\], a metabolite of pyrene, and 3-hydroxybenzo(a)pyrene \[3-OHBaP\], a metabolite of benzo(a)pyrene). Metals will be analyzed using ICP-MS \[[@ref21]\], whereas the PAH metabolites will be analyzed using high-performance liquid chromatography with fluorescence detection (HPLC-Fluo) \[[@ref22]\]. Finally, a more sensitive method for analyzing urinary NDELA will be developed based on high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS).

Inflammation and Oxidative or Nitrosative Stress Biomarkers
-----------------------------------------------------------

### Inflammation Biomarker

Nitric oxide is a biomarker of bronchial inflammation often used \[[@ref23]\] in an occupational context, and it is related to other inflammation markers like nonspecific bronchial hyperresponsiveness, a presumed precursor of asthma \[[@ref24]\]. FeNO is a noninvasive and easy method of measuring nitric oxide, with standardized commercial devices (Niox Vero) available.

### Oxidative or Nitrosative Stress Biomarkers in Exhaled Breath Condensate

Following Basu \[[@ref25]\]:

> Isoprostanes, mainly 8-iso-PGF2αand 8-iso-PGE2, possess potent biologic effects in a number of biologic systems, and thus they may also serve as pathologic mediators of oxidant stress through their vasoconstrictive and inflammatory properties.

8-iso-prostaglandin F~2α~ (8-iso-PGF~2α~) is a marker of a pathway in the free radical lipid peroxidation mechanism, and therefore fits our presumed mechanism shown in [Figure 1](#figure1){ref-type="fig"}. Malondialdehyde (MDA) is another indirect marker of lipid peroxidation, although it is considered less specific. Concentrations of 8-Oxo-2\'-deoxyguanosine (8-OHdG) are considered a trace of a repairing/excretion mechanism for oxidized guanine and are considered a measure of whole-body oxidative stress. 8-isoprostane and 8-OHdG will be analyzed following the publication by Syslova \[[@ref26]\] using HPLC-MS/MS. The same technique will be used for MDA analysis after a derivatization step.

Nitrites and nitrates have previously been identified as pollutants in aqueous MWF and are markers of nitrosative stress \[[@ref27],[@ref28]\]. These two anions will be measured in EBC by ion chromatography.

### Oxidative Stress Biomarkers in Urine

8-isoprostane, MDA and 8-OHdG will also be analyzed in the urine using HPLC-MS/MS \[[@ref29],[@ref30]\].

Genotoxic Effects and Respiratory Symptoms
------------------------------------------

### Markers of Genotoxicity

Genotoxicity from MWF aerosol exposure will be assessed using the buccal micronucleus cytome assay \[[@ref31]\]. The presence of micronuclei in buccal cells is considered a sign of damage to the DNA and of chromosomal instability. Buccal cells will be harvested from each participant. Using a microscope with white and fluorescent light, the cells will be stained using cytoplasmic and DNA staining and then 2000 cells will be scored for the presence of micronuclei or nuclear buds. A number of occupational exposures have given rise to excess numbers of micronuclei \[[@ref32]\].

### Respiratory Symptoms

Symptoms of chronic bronchitis and asthma-like conditions will be explored using the standardized Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy (EGEA) questionnaire \[[@ref33]\]. In addition, the questionnaire will ask for cutaneous symptoms (eczema or eczema-like symptoms).

Statistical Methods and Power
-----------------------------

The statistical analysis will follow the presumed causal model ([Figure 2](#figure2){ref-type="fig"}) and will be performed using the Stata (StataCorp LP, College station, Texas) statistical software. The first analysis will model the exposure measurements as a function of the determinants using linear models, after suitable transformations (logarithmic) if necessary. The exposure biomarkers in EBC and urine will be modelled as a function of the exposure measurements as well as possibly the exposure determinants. These analyses will focus on the within-shift evolution of these markers and will be based on mixed models. Measurements below the limits of detection will be included using specific models (random effect Tobit or Bayesian models) \[[@ref34]\]. The biomarkers of effect and the FeNO will be analyzed as a function of the exposure measurements and determinants using similar statistical models. Again, the focus will be on the within-shift evolution but also on the evolution over the three days. The effects from the circadian cycle will be controlled by the simultaneous modelling of the nonexposed subjects. The prevalence of symptoms and the frequency of micronuclei will be analyzed using logistic regression as a function of the exposed or nonexposed status and the chronic occupational exposure that will be estimated from the job history and the exposure determinants. Note that in the analysis of the frequency of micronuclei, the number of collected cells per subject will be included as an offset and that this analysis will account for a possible overdispersion using a negative binomial regression. Possible confounders such as smoking, age, sex and diet will be accounted for in the different statistical analyses.

The study size was determined based on the longitudinal evolution of FeNO and the comparison of the frequency of micronuclei in two exposure groups. According to Bohadana et al \[[@ref35]\], a 10% increase of FeNO between 2 measurements corresponds to an 80% power at a 5% significance level with a sample of 30 subjects.

With respect to micronuclei, assuming a 0.74% \[[@ref36]\] baseline prevalence among controls, we have an 80% power at a 5% significance level with two samples of 30 subjects. This allows us to detect a 2.2 rate ratio between an exposed and a nonexposed group assuming a 1.5 between-subject geometric SD.

The rationale behind choosing the number of controls in a 1:2 ratio to exposed workers is to get equal sized exposure groups between the aqueous exposed works, the straight oil exposed workers, and the controls.

Study Organization
------------------

The present study is carried out by a consortium of three organizations: (1) Team 1, the research team EA 4483 from the IMPact de l'Environnement Chimique sur la Santé humaine (IMPECS; Impact of the chemical environment on human health) of the University of Lille in France; (2) Team 2, Unisanté, the department of occupational and environmental health from the University of Lausanne in Switzerland; and finally (3) Team 3, the Institut National de Recherche et de Sécurité (INRS; French National Institute for Research and Safety) in France.

The study is coordinated by the INRS. A Consortium Agreement specifying the legal, financial and scientific framework of the cooperation regarding the present study was signed by the three organizations on March 22, 2017.

Two parallel groups of scientists in Switzerland and France with common operational procedures carry out the on-site data collection. To minimize laboratory bias, most of the samples are dispatched to and analyzed by one laboratory only. All organic biomarkers in urine and EBC, as well as the micronuclei frequency in buccal cells, will be analyzed by team 3. The metals in EBC will be analyzed \[[@ref14]\] by team 1. Team 2 will characterize MWF aerosol for its oxidative potential, organic carbon, nitrate, nitrite and aldehyde content as well as the formate concentration in EBC. Both Team 2 and 3 will determine the particulate exposure.

All electronic documents related to the study are deposited in a structured, encrypted extranet located on a server of team 3. The access to this extranet is strictly restricted to the study team members by an individual password. Measurement data from each lab will be deposited by the laboratories generating them. All deposited data will be anonymous, and the rules for generating the identification codes are defined by an operational procedure. The data on the extranet will be saved daily and backups will be kept in a separate building from the server. The deposited data will be organized and prepared for data analysis in the three months after collection by the same data manager, who will provide regular feedback on the data collection.

Ethics and Data Dissemination
-----------------------------

This study was approved by the ethical committee of the canton Vaud, Switzerland (Commission cantonale d'éthique de la recherche sur l'être humain CER-VD) on June 13, 2017, project number 2017-00630, and by France (Comité de Protection des Personnes Sud-Est) on May 17, 2017, project number 17-02-EE-VD/OXIGENOCOM.

Several scientific, peer-reviewed publications are planned. The first ones will correspond to the preparatory phases (eg, a scientific article on the determination of biomarkers in EBC, a paper on automatic versus human-based counting of micronuclei in buccal cells). The other planned papers will respectively correspond to the objectives described in the beginning of this paper.

The ultimate objective is to develop relevant exposure reduction strategies. The results will be published in a nonscientific format and will be accessible by environmental health and safety professionals.

Depending on the corresponding legal authorizations, parts or all of the data will be deposited on a public data repository after the final publications.

Results
=======

Our study is organized into three partially overlapping periods. The first period started October 2016 and ended December 2017 and was dedicated to: (1) obtaining the ethics committees' consents; (2) writing and agreeing on operational procedures; (3) setting up a study-specific data extranet; and (4) validating analytical laboratory procedures.

The second period started with a pilot study conducted from February 12, 2018 to Feb 14, 2018. The subsequent debriefing led to minor adjustments of the daily organization of the data collection. The data collection will end in June 2019. At the time of writing, 100 subjects from 17 companies have been included, comprising 29 control subjects. An additional three companies will be included.

The third period consists of laboratory analysis, data management, and data analysis. Written feedback will be provided to participants and companies related to exposure. Finally, a scientific report will be sent to the funding agency in April 2020, and results will be published in peer-reviewed journals.

Discussion
==========

A strength of this project is its hypothesis driven and multidisciplinary approach. First, the diversity of biomarkers will shed some light on the physiopathological mechanisms. Second, the extensive exposure assessment by occupational hygienists will help in characterizing components that have a short-term effect on the measured biomarkers. Finally, recording exposure determinants will help with focusing the future exposure preventions so that they have the greatest potential impact on workers' health.

One of the most interesting parameters is the oxidative potential of the MWF aerosol. We hypothesize that oxidative potential is a measure capturing the overall oxidative stress generated by the aerosol and would thus be independent of the inert (or nonreactive) constituents such as hydrocarbons. Thus, one of the most interesting relationships to be explored is between oxidative potential and the biomarkers of effect, in particular the biomarkers of oxidative stress. In the words of Dr Ken Donaldson \[[@ref13]\]:

> The measurement of the oxidative potential of ambient particles would represent a more refined metric, bringing it closer to the Biological Effect Dose with anticipated improvements in risk management and better associations with adverse health effects in epidemiological studies.

Indeed, diverse approaches to assessing occupational exposure give us the tools to characterize what might be the biological effect dose.

Another strength is the noninvasive biomarker collection approach. Respiratory symptoms and urinary biomarkers, and to a lesser extent FeNO, are often used in occupational epidemiology. EBC and micronuclei frequencies in buccal cells are not routinely used yet; however, these biomarkers have shown great promise in earlier work from our research group \[[@ref28],[@ref29],[@ref32],[@ref37],[@ref38]\]. Thus, the markers developed in this project could potentially be used in routine monitoring of exposed workers.

An important aspect of our study is that the relationships we want to study are in two different time-frames. The relationships between the exposure measurements and the evolution of the biomarkers, be they measured in exhaled air, its condensate or in urine, reflect short-term relationships. The second time frame we consider is chronic. Neither the respiratory symptoms nor the micronuclei frequency are assumed to vary in the 2 days of data collection. These outcomes are therefore obtained only once and reflect long-term effects. To some extent, we could also consider the effect markers measured Monday morning as possible long-term markers. However, when analyzing these outcomes as a function of exposure, we have to consider long-term exposure. The latter is necessarily less precise than the measured exposure because it has to be assessed using the jobs' histories and tasks recorded in the questionnaire.

The constraints of our study protocol entailed a very intensive field data collection from no more than 4 study subjects, with 4 researchers and technicians present in the companies over 4 days. This is the drawback of the very complete exposure assessment, but also of the required participation time from each worker, and finally of the required 2-day unexposed period before inclusion. The total sample size is thus limited. To be able to identify the exposure measurements that are closest to the biological effective dose, it will be necessary to include workers, and hence companies, with varied exposure characteristics both qualitatively and in terms of exposure concentrations. Bacterial contamination and endotoxin measurements were not included due to limited resources. Nevertheless, our protocol reflects a multidisciplinary approach and allows small or very small companies to be included. Consequently, the likelihood of having high exposure levels is greater compared to large companies, which are the ones usually explored in epidemiological studies.

Thus, the possible lack of power induced by the relatively small number of included subjects will be compensated for by the large exposure variance when including both highly exposed and less exposed workers. It is noteworthy that the repeated measure design (five measurements per subject for urine and two for EBC) will contribute to increase the power of detecting short-term effects.

For outcomes collected only once reflecting long-term effects (respiratory symptoms or micronuclei), the power will correspondingly be lower, especially as the chronic exposure estimate will be less precise and possibly affected by exposure misclassification. As shown previously, one would need an odds ratio greater than 2 to be able to detect such effects.

Related to statistical power is the issue of multiplicity. Indeed, the number of outcomes will be quite large, so a number of statistical models will be fitted to more or less the same data. Thus, with the exception of the central hypothesis relating oxidative potential measurements to oxidative stress, it will certainly be safe to consider some analyses as exploratory or to assign some multiplicity correction to any *P* value.

Conclusion
----------

This study is unique, as it comprises human biological samples, questionnaires, and MWF exposure measurement. The aim is to develop preventative strategies based on exposure determinants related to health outcomes. To achieve this goal, this integrative multidisciplinary approach quantifies the relationships between exposure determinants, exposure measurements, biomarkers of exposure, biomarkers of effect, and early effect outcomes.

The present protocol was funded by The French National Research Program for Environmental and Occupational Health of ANSES, with the support of the Cancer TMOI of the French National Alliance for Life and Health Sciences (AVIESAN) (EST-2016/1/166). The funding period is 40 months, starting October 21, 2016.
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